129 related articles for article (PubMed ID: 8275617)
1. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
Kinirons MT; O'Shea D; Downing TE; Fitzwilliam AT; Joellenbeck L; Groopman JD; Wilkinson GR; Wood AJ
Clin Pharmacol Ther; 1993 Dec; 54(6):621-9. PubMed ID: 8275617
[TBL] [Abstract][Full Text] [Related]
2. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.
Kinirons MT; O'Shea D; Kim RB; Groopman JD; Thummel KE; Wood AJ; Wilkinson GR
Clin Pharmacol Ther; 1999 Sep; 66(3):224-31. PubMed ID: 10511057
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol.
Hunt CM; Watkins PB; Saenger P; Stave GM; Barlascini N; Watlington CO; Wright JT; Guzelian PS
Clin Pharmacol Ther; 1992 Jan; 51(1):18-23. PubMed ID: 1732074
[TBL] [Abstract][Full Text] [Related]
4. Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.
Kinirons MT; Krivoruk Y; Wilkinson GR; Wood AJ
Br J Clin Pharmacol; 1999 Feb; 47(2):223-5. PubMed ID: 10190659
[No Abstract] [Full Text] [Related]
5. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
Chiou WL; Jeong HY; Wu TC; Ma C
Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
[No Abstract] [Full Text] [Related]
6. Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients.
Schmidt LE; Olsen AK; Stentoft K; Rasmussen A; Kirkegaard P; Dalhoff K
Clin Pharmacol Ther; 2001 Nov; 70(5):446-54. PubMed ID: 11719731
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
Stein CM; Kinirons MT; Pincus T; Wilkinson GR; Wood AJ
Clin Pharmacol Ther; 1996 Jan; 59(1):47-51. PubMed ID: 8549033
[TBL] [Abstract][Full Text] [Related]
8. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity.
Watkins PB; Turgeon DK; Saenger P; Lown KS; Kolars JC; Hamilton T; Fishman K; Guzelian PS; Voorhees JJ
Clin Pharmacol Ther; 1992 Sep; 52(3):265-73. PubMed ID: 1526083
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.
Zhang XJ; Thomas PE
Drug Metab Dispos; 1996 Jan; 24(1):23-7. PubMed ID: 8825186
[TBL] [Abstract][Full Text] [Related]
10. Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion.
Seidegård J; Dahlström K; Kullberg A
Clin Exp Pharmacol Physiol; 1998 May; 25(5):379-81. PubMed ID: 9612666
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.
Ohno M; Yamaguchi I; Ito T; Saiki K; Yamamoto I; Azuma J
Eur J Clin Pharmacol; 2000; 55(11-12):861-5. PubMed ID: 10805065
[TBL] [Abstract][Full Text] [Related]
12. Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors.
Gass RJ; Gal J; Fogle PW; Detmar-Hanna D; Gerber JG
Eur J Clin Pharmacol; 1998; 54(9-10):741-7. PubMed ID: 9923578
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
14. Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.
Horsmans Y; Desager JP; Harvengt C
Pharmacol Toxicol; 1992 Oct; 71(4):258-61. PubMed ID: 1454750
[TBL] [Abstract][Full Text] [Related]
15. Influence of amiodarone on urinary excretion of 6beta-hydroxycortisol in humans.
Micuda S; Hodac M; Sispera L; Parízek P; Pleskot M; Zimova G; Cerman J; Martínková J; Pidrman V
Physiol Res; 2001; 50(2):191-6. PubMed ID: 11522047
[TBL] [Abstract][Full Text] [Related]
16. Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.
Hunt CM; Westerkam WR; Stave GM; Wilson JA
Mech Ageing Dev; 1992 Jun; 64(1-2):189-99. PubMed ID: 1630156
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of cytochrome P4503A substrates in vivo administered by the same route: lack of correlation between alfentanil clearance and erythromycin breath test.
Krivoruk Y; Kinirons MT; Wood AJ; Wood M
Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):608-14. PubMed ID: 7995002
[TBL] [Abstract][Full Text] [Related]
18. Mdr1 limits CYP3A metabolism in vivo.
Lan LB; Dalton JT; Schuetz EG
Mol Pharmacol; 2000 Oct; 58(4):863-9. PubMed ID: 10999959
[TBL] [Abstract][Full Text] [Related]
19. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily.
Rodrigues AD; Roberts EM; Mulford DJ; Yao Y; Ouellet D
Drug Metab Dispos; 1997 May; 25(5):623-30. PubMed ID: 9152603
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urinary 6beta-hydroxycortisol/cortisol ratio between neonates and their mothers.
Nakamura H; Hasegawa A; Kimura M; Yamagata S; Nakasa H; Osada H; Sekiya S; Ohmori S; Kitada M
Br J Clin Pharmacol; 1999 Jan; 47(1):31-4. PubMed ID: 10073736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]